Decoy Therapeutics Inc. (DCOY): Shareholders' Equity
$5.89M
As of 2025-12-31
$4.32M
As of 2026-06-30
-17.2%
3-year compound annual growth
-23.3%
5-year compound annual growth
-24.0%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.89M | +289.6% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.51M | -71.4% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.29M | -49.1% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $10.38M | -73.2% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $38.72M | +74.7% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $22.16M | +109.4% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $10.58M | n/m | 2021-03-18, Balance as of period end |
| 2018-12-31 | -$1.27M | n/m | 2020-03-23, Balance as of period end |
| 2017-12-31 | $29.11M | -50.9% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $59.32M | -35.7% | 2019-03-06, Balance as of period end |
| 2015-12-31 | $92.19M | n/m | 2018-03-07, Balance as of period end |
| 2014-12-31 | -$6.54M | n/a | 2017-03-08, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.89M | +289.6% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $6.53M | -69.2% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $10.39M | +372.4% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $5.33M | -32.8% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $7.25M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | -$629.0K | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.22M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $8.86M | +88.2% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $2.25M | +217.9% |
Compare DCOY, LTRN, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗